Investor Presentation slide image

Investor Presentation

Introduction & overview Financial results Strategy & outlook Conclusions Appendices COPUREGYM Group cash flow Q2 2022 • • Group Adjusted EBITDA of £26m converted to £21m of operating cash inflow Cash inflow from working capital movement due to new site roll-out. Inflow lower than prior year due to settlement of deferred liabilities, as well as changes in operating model in Switzerland to monthly membership • Maintenance & refurbishment capex at £6.4m in the quarter, reflecting a rising number of refurbishments as the Group invests in the existing estate . Expansionary capex includes expenditure on the completion of 9 new corporate owned sites opened in the quarter & commencement of works on new sites to be opened after the period end Cash outflow for exceptional items in the period mainly reflects the settlement of exceptional expenditure incurred in 2021 "Other" cash outflow mainly relates to the repayment of Covid rent due from prior periods • Other financing cash outflows of £7.2m includes the repayment of short term financing £m Group Adjusted EBITDA Group operating cash flow Operating cash flow conversion Expansionary capital expenditure Exceptional items 3 months ended 30 Jun 6 months ended 30 Jun 2022 2021 2022 2021 25.9 16.4 50.9 (9.0) Movement in working capital 1.9 9.3 (8.8) 7.3 Maintenance & refurb capital expenditure (6.4) (4.6) (9.0) (6.1) 21.4 21.1 33.2 (7.7) 82% 129% 65% n/a (15.7) (12.5) (25.2) (21.2) (1.5) (4.6) (1.7) 6.1 (11.8) (11.7) (26.0) (26.8) (4.9) (6.6) (16.4) (6.0) Net cash flow before acquisition & financing Issue of senior secured notes Equity injection (12.6) (14.2) (36.1) (55.6) 38.9 270.0 (1.6) (2.0) (3.2) (3.9) (7.2) 6.7 (9.6) 6.8 (21.5) (9.5) 221.1 (13.7) Tax, interest, & debt issue costs Other Finance lease capital repayments Other financing cash flows Net cash flow Investor Presentation 25 August 2022 24
View entire presentation